KRAS inhibitor-12
KRAS inhibitor-12 (compound 6-1) is a potent KRAS G12C inhibitor with an IC50 of 0.537 µM. KRAS inhibitor-12 shows p-ERK inhibition activities with IC50s of 1.3, 3.7 µM in MIA PaCA-2, A549 cells, respectively. KRAS inhibitor-12 has the potential for the research of pancreatic, colorectal, and lung cancers[1].
Product Specifications
CAS Number
[2230874-00-5]
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-inhibitor-12.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CCN(CC1)C2=C3C=C(Cl)C(C4=C(Cl)C=CC(N)=N4)=C(F)C3=NS2)C=C
Molecular Formula
C19H16Cl2FN5OS
Molecular Weight
452.33
References & Citations
[1]Brian alan, et al. KRAS g12c inhibitors and methods of using the same. WO2018119183 A2
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Rabbit anti-Escherichia coli O9:H4 (strain HS) rplD Polyclonal Antibody
Recombinant Burkholderia ambifaria Crossover junction endodeoxyribonuclease RuvC (ruvC)
Recombinant Burkholderia ambifaria Crossover junction endodeoxyribonuclease RuvC (ruvC)
Recombinant Burkholderia ambifaria Crossover junction endodeoxyribonuclease RuvC (ruvC)
Recombinant Burkholderia ambifaria Crossover junction endodeoxyribonuclease RuvC (ruvC)